LER & CER: letter to Editor Rheumatology
Reply to: Use of upadacitinib in giant cell arteritis
D. Blockmans1, W. Zhao2, A.R. Setty3, P.A. Merkel4
- Department of General Internal Medicine, University Hospitals Leuven; Department of Microbiology, Immunology, and Transplantation, KU Leuven, Belgium. daniel.blockmans@uzleuven.be
- Immunology, AbbVie Inc., North Chicago, IL, USA.
- Immunology, AbbVie Inc., North Chicago, IL, USA.
- Division of Rheumatology, Department of Medicine, Division of Epidemiology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
CER19239
LER & CER: letter to Editor Rheumatology
Free to view
(click on article PDF icon to read the article)
PMID: 41004311 [PubMed]
Received: 25/08/2025
Accepted : 01/09/2025
In Press: 25/09/2025
